FindTrial
Sign In

Monitoring kinetics of cytokines and growth factors before and after liver resection

Monitoring kinetics of cytokines and growth factors before and after liver resection - Monitoring Kinetics of cytokines and growth factors before and after liver resection

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000026380
Enrollment
100
Registered
2017-03-03
Start date
2013-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

None listed

Sponsors

Cardiovascular and Gastroenterological surgery, Kagoshima University Graduate School of Medical and Dental Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hepatocellular carcinoma patients who undergoes liver resection

Exclusion criteria

Exclusion criteria: Patients taking anti-platelet drugs, platelet transfusion and psychosomatic medicines

Design outcomes

Primary

MeasureTime frame
Evaluating platelet-derived serotonin association with early (less than 2 years) and late (more than 2 years) Hepatocellular carcinoma recurrence after liver resection—

Secondary

MeasureTime frame
Vascular endothelial growth factor-A, TNF, IL-6, Hepatocyte growth factor, Angiopoietin 1 and 2, Epidermal growth factor, soluble Vascular endothelial growth factor receptor 1 and 2, Insulin-like growth factor 1 and 2, TGF beta, Angiotensin-(1-7), ACE and ACE2, Platelet derived growth factor-BB—

Countries

Japan

Contacts

Public ContactToshiaki Shimizu

Kagoshima University Graduate School of Medical and Dental Sciences Laboratory and Vascular Medicine

tshimizu@m.kufm.kagoshima-u.ac.jp099-275-5437

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026